Ibex director Khaishgi Mohammedulla sells $2.02 million in shares

IBEX Ltd (NASDAQ:IBEX) director Khaishgi Mohammedulla sold 70,000 shares for approximately $2.02 million over two days, according to an SEC filing, while retaining 7,312 shares; the sales occurred under a pre-arranged trading plan. The transactions follow a period where IBEX stock surged 75% over the past year and coincide with recent news including record Q3 2025 revenue of $140.7 million, an 11% increase year-over-year, and raised full-year revenue guidance, though Baird analysts recently downgraded the stock to Neutral with a $30 price target.

Analysis

IBEX Ltd. (NASDAQ:IBEX) has demonstrated robust operational performance, reporting record Q3 2025 revenue of $140.7 million, an 11% year-over-year increase, and an 18% rise in adjusted EPS to $0.82, surpassing market expectations and leading to raised full-year revenue guidance of $540-$545 million. This financial strength is underpinned by a strategic shift towards digital and omnichannel services, which now constitute 81% of total revenue, and a focus on AI solutions, exemplified by the appointment of a Global Head of Business Development for its Wave iX platform. Despite these positive developments and a significant 75% stock price surge over the past year for the $371 million market cap company, a director, Khaishgi Mohammedulla, recently sold 70,000 shares for approximately $2.02 million across two days at weighted average prices of $29.6622 and $28.0756, reducing his stake to 7,312 shares; this sale, however, was conducted under a pre-arranged trading plan, which often mitigates concerns of negative insider sentiment. Concurrently, Baird analysts downgraded IBEX from Outperform to Neutral, setting a $30.00 price target, though they maintained a positive view on the company's growth narrative and success in capturing market share in a low single-digit growth sector. From a valuation perspective, IBEX trades at a P/E ratio of 13.6, which InvestingPro deems attractive, with its Fair Value analysis suggesting the stock is slightly undervalued, although InvestingPro's ProPicks AI did not identify IBEX as a top-tier opportunity for massive upside.

Key Decisions for Investors

• Investors should interpret the director's $2.02 million share sale within the context of a pre-arranged trading plan and the stock's substantial 75% appreciation over the past year, which may suggest profit-taking rather than a fundamental bearish view.
• Evaluate IBEX's strong Q3 2025 financial results, including an 11% YoY revenue increase to $140.7 million, an 18% EPS uplift, and raised full-year guidance, in conjunction with its strategic focus on AI and digital services, an attractive P/E ratio of 13.6, and InvestingPro's assessment of slight undervaluation.
• Consider the recent Baird downgrade to Neutral with a $30 price target as a potential influence on near-term stock performance, weighing it against the analysts' continued positive commentary on IBEX’s growth prospects and the company's fundamental strengths.